Two Sigma Investments’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.12M | Buy |
86,362
+49,007
| +131% | +$638K | ﹤0.01% | 2131 |
|
2025
Q1 | $396K | Buy |
37,355
+9,795
| +36% | +$104K | ﹤0.01% | 2557 |
|
2024
Q4 | $468K | Buy |
27,560
+10,430
| +61% | +$177K | ﹤0.01% | 2506 |
|
2024
Q3 | $398K | Buy |
17,130
+3,812
| +29% | +$88.5K | ﹤0.01% | 2502 |
|
2024
Q2 | $324K | Sell |
13,318
-942
| -7% | -$22.9K | ﹤0.01% | 2484 |
|
2024
Q1 | $482K | Sell |
14,260
-11,400
| -44% | -$385K | ﹤0.01% | 2290 |
|
2023
Q4 | $809K | Buy |
25,660
+5,100
| +25% | +$161K | ﹤0.01% | 2125 |
|
2023
Q3 | $525K | Buy |
20,560
+500
| +2% | +$12.8K | ﹤0.01% | 2181 |
|
2023
Q2 | $575K | Buy |
20,060
+8,600
| +75% | +$247K | ﹤0.01% | 2201 |
|
2023
Q1 | $275K | Buy |
+11,460
| New | +$275K | ﹤0.01% | 2384 |
|
2021
Q4 | – | Sell |
-7,444
| Closed | -$356K | – | 2566 |
|
2021
Q3 | $356K | Sell |
7,444
-318,049
| -98% | -$15.2M | ﹤0.01% | 2128 |
|
2021
Q2 | $11M | Sell |
325,493
-67,210
| -17% | -$2.27M | 0.03% | 601 |
|
2021
Q1 | $16.2M | Buy |
392,703
+229,613
| +141% | +$9.48M | 0.04% | 433 |
|
2020
Q4 | $7.08M | Sell |
163,090
-113,228
| -41% | -$4.91M | 0.02% | 611 |
|
2020
Q3 | $11.9M | Buy |
276,318
+183,572
| +198% | +$7.88M | 0.04% | 388 |
|
2020
Q2 | $4.34M | Buy |
92,746
+69,704
| +303% | +$3.26M | 0.02% | 589 |
|
2020
Q1 | $313K | Sell |
23,042
-52,620
| -70% | -$715K | ﹤0.01% | 1418 |
|
2019
Q4 | $822K | Buy |
75,662
+60,868
| +411% | +$661K | ﹤0.01% | 1498 |
|
2019
Q3 | $152K | Buy |
+14,794
| New | +$152K | ﹤0.01% | 1788 |
|
2017
Q3 | – | Sell |
-3,186
| Closed | -$25K | – | 1890 |
|
2017
Q2 | $25K | Buy |
3,186
+100
| +3% | +$785 | ﹤0.01% | 1953 |
|
2017
Q1 | $25K | Buy |
+3,086
| New | +$25K | ﹤0.01% | 2071 |
|
2015
Q1 | – | Sell |
-4,303
| Closed | -$112K | – | 2108 |
|
2014
Q4 | $112K | Buy |
+4,303
| New | +$112K | ﹤0.01% | 2124 |
|